{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:22:46Z","timestamp":1779909766173,"version":"3.53.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.seizure.2017.09.019","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T04:48:16Z","timestamp":1507092496000},"page":"76-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Safety of intravenous lacosamide in critically ill children"],"prefix":"10.1016","volume":"52","author":[{"given":"Sarah S.","family":"Welsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Topjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Abend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.09.019_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12028-008-9061-3","article-title":"Development of a pediatric neurocritical care service","volume":"10","author":"Bell","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2017.09.019_bib0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pediatrneurol.2012.12.006","article-title":"Pediatric neurocritical care: a neurology consultation model and implication for education and training","volume":"48","author":"LaRovere","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WNP.0000000000000166","article-title":"Consensus statement on continuous EEG in critically ill adults and children, part I: indications","volume":"32","author":"Herman","year":"2015","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/WNP.0b013e31827eda27","article-title":"Pediatric ICU EEG monitoring: current resources and practice in the United States and Canada","volume":"30","author":"Sanchez","year":"2013","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e31829c5cfe","article-title":"Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality","volume":"81","author":"Abend","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.09.019_bib0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/brain\/awu042","article-title":"Seizure burden is independently associated with short term outcome in critically ill children","volume":"137","author":"Payne","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2017.09.019_bib0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CCM.0b013e3182668035","article-title":"Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children","volume":"41","author":"Topjian","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2017.09.019_bib0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.0000000000000082","article-title":"Electrographic status epilepticus and long-term outcome in critically ill children","volume":"82","author":"Wagenman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.09.019_bib0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12028-010-9337-2","article-title":"Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists","volume":"12","author":"Abend","year":"2010","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.seizure.2017.09.019_bib0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.seizure.2013.03.008","article-title":"Treatment of electrographic seizures and status epilepticus in critically ill children: a single center experience","volume":"22","author":"Abend","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.seizure.2013.10.004","article-title":"Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG)","volume":"23","author":"Sanchez Fernandez","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0060","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/epi.13466","article-title":"Lacosamide use in children with epilepsy: retention rate and effect of concomitant sodium channel blockers in a large cohort","volume":"57","author":"McGinnis","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.09.019_bib0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.seizure.2013.07.011","article-title":"Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study","volume":"22","author":"Belcastro","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.seizure.2013.12.004","article-title":"Lacosamide in absence status epilepticus","volume":"23","author":"d\u2019Orsi","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2016.09.004","article-title":"Intravenous lacosamide in seizure emergencies: observations from a hospitalized in-patient adult population","volume":"42","author":"d\u2019Orsi","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12028-010-9501-8","article-title":"The use of lacosamide in refractory status epilepticus","volume":"14","author":"Goodwin","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2017.09.019_bib0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pediatrneurol.2010.12.003","article-title":"Experience with lacosamide in a series of children with drug-resistant focal epilepsy","volume":"44","author":"Guilhoto","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/WNF.0b013e31829b21ba","article-title":"Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review","volume":"36","author":"Hawkes","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"Hofler","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.09.019_bib0100","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1111\/j.1528-1167.2011.03204.x","article-title":"Intravenous lacosamide in status epilepticus and seizure clusters","volume":"52","author":"Hofler","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.09.019_bib0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1528-1167.2012.03419.x","article-title":"Treatment of refractory tonic status epilepticus with intravenous lacosamide","volume":"53","author":"Jain","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.09.019_bib0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2010.01423.x","article-title":"Intravenous lacosamide for treatment of status epilepticus","volume":"123","author":"Kellinghaus","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2017.09.019_bib0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ane.12174","article-title":"Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus","volume":"129","author":"Kellinghaus","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2017.09.019_bib0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.2010.01430.x","article-title":"Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus","volume":"123","author":"Koubeissi","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2017.09.019_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2012.10.004","article-title":"Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study","volume":"22","author":"Miro","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2011.12.008","article-title":"Intravenous Lacosamide in refractory nonconvulsive status epilepticus","volume":"21","author":"Mnatsakanyan","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.09.019_bib0135","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s00415-013-7133-6","article-title":"Usefulness of intravenous lacosamide in status epilepticus","volume":"260","author":"Santamarina","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40263-013-0049-y","article-title":"Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study","volume":"27","author":"Sutter","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2017.09.019_bib0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejpn.2015.12.013","article-title":"Clinical experience of intravenous lacosamide in infants and young children","volume":"20","author":"Arkilo","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0150","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpn.2014.04.013","article-title":"Lacosamide in children with refractory status epilepticus: a multicenter Italian experience","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pediatrneurol.2016.03.021","article-title":"Intravenous lacosamide in pediatric status epilepticus: an open-label efficacy and safety study","volume":"61","author":"Poddar","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.09.019_bib0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)?a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inf"},{"key":"10.1016\/j.seizure.2017.09.019_bib0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-3476(05)82544-2","article-title":"Assessing the outcome of pediatric intensive care","volume":"121","author":"Fiser","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.seizure.2017.09.019_bib0170","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/00003246-200007000-00072","article-title":"Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2017.09.019_bib0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/euhj.2000.2399","article-title":"New normal limits for the paediatric electrocardiogram","volume":"22","author":"Rijnbeek","year":"2001","journal-title":"Eur Heart J"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:48Z","timestamp":1761011388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117301796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":35,"alternative-id":["S1059131117301796"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.09.019","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of intravenous lacosamide in critically ill children","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}